Immunome: SpringWorks Buyout Informs The Potential Upside Here
Immunome(US:IMNM) Seeking Alphaยท2025-08-12 02:31Group 1 - Immunome, Inc. (NASDAQ: IMNM) has been previously covered with a pessimistic view on the sustainability of its rally, which was driven by non-clinical data catalysts [1] - The author has a PhD in biochemistry and extensive experience in analyzing clinical trials and biotech companies, emphasizing the importance of understanding the science behind investments [1] Group 2 - The article does not provide any specific financial data or performance metrics related to Immunome, Inc. or the biotech industry [2][3]